The global generic oncology pharmaceuticals market was valued at $24.5 billion in 2022 and is expected to grow at a 6% CAGR between 2022 and 2028, reaching more than $34.8 billion by the end of 2028. Increasing inclination of individuals towards smoking and tobacco consumption is the chief cause of cancer. Secondary factors such as …